BioCentury
ARTICLE | Product Development

Defining access potential - before it’s too late

Guest commentary: Companies need to define access potential before it’s too late

June 30, 2018 2:23 AM UTC

We see it everywhere: confirmation bias.

Innovators believe in a drug, find the evidence to support its value, and dismiss or ignore the facts challenging their preferred story. ...